J9225 Histrelin Acetate - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Histrelin Acetate

Brand Name:

Vantas

Strength:

50 mg

HCPCS:

J9225

SEER*Rx Category:

Hormonal Therapy

Major Drug Class:

GnRH Agonist

Minor Drug Class:

Oral (Y/N):

No

FDA Approval Year:

2004

FDA Discontinuation Year:

CMS Effective Date:

Jan. 1, 2008

CMS Discontinuation Date:

Status:

In Use